" ( ) "

³ ( )

 (0)

 (0)

    
  1 / 1 |   | | viewdetails | |  
 # 99589
Ѳ ֲ Ҳ ˲ ̲ IJ в òDz
      (uk)     (ru)     (en)      
  䳺
(11) 99589 (51)
A61B 5/02 (2006.01)
(24) 10.06.2015
(21) u201500093 (22) 06.01.2015
(46) 10.06.2015, . 11
(71) " ֲ Ͳ" (UA )
...................................................................................................................................................................
" " (UA )
...................................................................................................................................................................
"UZHHOROD NATIONAL UNIVERSITY" STATE HIGHER EDUCATIONAL INSTITUTION (UA )
(72) (UA ); (UA ); (UA ); (UA ); (UA ); (UA ); (UA )
...................................................................................................................................................................
(UA ); (UA ); (UA ); (UA ); (UA ); (UA ); (UA )
...................................................................................................................................................................
Chubiko Kseniya Ivanivna (UA ); Chernyak Myhailo Myhailovych (UA ); Debretseny Kristian Oleksandrovych (UA ); Bychka Yaroslav Mykhailovych (UA ); Hechko Mykhailo Mykhailovych (UA ); Chopei Ivan Vasyliovych (UA ); Bychko Mykhailo Vasyliovych (UA )
(73) " ֲ Ͳ", . ϳ, 46, . , 88000 (UA )
...................................................................................................................................................................
" " (UA )
...................................................................................................................................................................
"UZHHOROD NATIONAL UNIVERSITY" STATE HIGHER EDUCATIONAL INSTITUTION (UA )
(98) ,
. ϳ, 46, . , 88000
(UA)
(54) Ѳ ֲ Ҳ ˲ ̲ IJ в òDz
...................................................................................................................................................................
METHOD FOR EVALUATING THE EFFECTIVENESS OF EPROSARTAN TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND ANGINA AND HYPERTENSION
...................................................................................................................................................................
(57)
   
 
0.583925962448